Cite

HARVARD Citation

    Wu, J. et al. (2021). A novel STING agonist for cancer immunotherapy and a SARS-CoV-2 vaccine adjuvant. Chemical communications. 57 (4), pp. 504-507. [Online]. 
  
Back to record